Derniers ajouts - Age-Related Macular Degeneration - Dry
|
Reticular pseudodrusenvu 124 fois23 Février 2025
|
|
Reticular pseudodrusenvu 134 fois23 Février 2025
|
|
Reticular pseudodrusenvu 124 fois23 Février 2025
|
|
Reticular pseudodrusenvu 102 fois23 Février 2025
|
|
Reticular pseudodrusenvu 115 fois23 Février 2025
|
|
Reticular pseudodrusenvu 104 fois23 Février 2025
|
|
Reticular pseudodrusenvu 125 fois23 Février 2025
|
|
Reticular pseudodrusenvu 122 fois23 Février 2025
|
|
Reticular pseudodrusenvu 121 fois23 Février 2025
|
|
Reticular pseudodrusenvu 120 fois23 Février 2025
|
|
Reticular pseudodrusenvu 129 fois23 Février 2025
|
|
Reticular pseudodrusenvu 120 fois23 Février 2025
|
|
Reticular pseudodrusenvu 113 fois23 Février 2025
|
|
Reticular pseudodrusenvu 133 fois23 Février 2025
|
|
Reticular pseudodrusenvu 127 fois23 Février 2025
|
|
Reticular pseudodrusenvu 136 fois23 Février 2025
|
|
Reticular pseudodrusenvu 125 fois23 Février 2025
|
|
Reticular pseudodrusenvu 110 fois23 Février 2025
|
|
Reticular pseudodrusenvu 109 fois23 Février 2025
|
|
Reticular pseudodrusenvu 111 fois23 Février 2025
|
|
Reticular pseudodrusenvu 112 fois23 Février 2025
|
|
54 year old female with a lot of drusenvu 109 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 102 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 107 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 101 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 125 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 118 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 120 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 126 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 154 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 148 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 138 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 140 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 164 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 152 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 157 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 142 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 157 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 140 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 140 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 126 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 114 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 123 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 153 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 159 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 143 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 154 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Optic Disc Melanocytoma - Atypicalvu 271 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 246 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 233 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 243 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 230 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 242 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 246 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 251 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 272 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 265 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 270 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 262 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 264 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 249 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 253 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 251 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 238 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 219 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 244 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 225 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 214 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Soft Drusenvu 265 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 283 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 268 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 259 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 264 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 293 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 268 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 246 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 257 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 280 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 275 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 267 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 290 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 275 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 267 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 301 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 292 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 249 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 278 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 268 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 246 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 267 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 256 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 279 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 284 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 295 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 245 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 265 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 277 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 296 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 284 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 313 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
| 582 photos sur 6 page(s) |
1 |
 |
|
|
|
